The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
VIVO Starts Extraction Operations in Napanee, Ontario
Jul. 30, 2019 05:19AM PST
Cannabis Investing NewsVIVO Cannabis (TSXV:VIVO,OTCQX:VVCIF) announced Tuesday (July 30) that the company’s subsidiary, ABcann Medicinals, has received approval from Health Canada to start extraction operations using its CO2 extraction system. As quoted in the press release: “We are extremely excited to commence CO2 extraction operations at our Napanee facility,” said Gary McMullen, Vice-President, Napanee Operations. “We are now capable …
VIVO Cannabis (TSXV:VIVO,OTCQX:VVCIF) announced Tuesday (July 30) that the company’s subsidiary, ABcann Medicinals, has received approval from Health Canada to start extraction operations using its CO2 extraction system.
As quoted in the press release:
“We are extremely excited to commence CO2 extraction operations at our Napanee facility,” said Gary McMullen, Vice-President, Napanee Operations. “We are now capable of producing cannabis oils and concentrates to our exact specifications, which is important for meeting our stated production targets to support the sales of our premium brands and customized offerings, including Canna Farms™, Fireside™, Lumina™ and Beacon Medical as well as providing extraction services to third parties.”
Upon receipt of EU-GMP certification for its Napanee facility, the Company is expected to be able to ship extracted cannabis products to Europe and other countries for scientific and medical purposes, subject to receipt of all necessary import and export permits, in addition to selling domestically.
“The launch of our extraction operation in Napanee reinforces our commitment to innovation as we pivot our Napanee facility into a high caliber and efficient producer of value-added cannabis-based products,” said Barry Fishman, CEO of VIVO.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.